Overlooked potential of positrons in cancer therapy

Positron (β(+)) emitting radionuclides have been used for positron emission tomography (PET) imaging in diagnostic medicine since its development in the 1950s. Development of a fluorinated glucose analog, fluorodeoxyglucose, labelled with a β(+) emitter fluorine-18 ((18)F-FDG), made it possible to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hioki, Takanori, Gholami, Yaser H., McKelvey, Kelly J., Aslani, Alireza, Marquis, Harry, Eslick, Enid M., Willowson, Kathy P., Howell, Viive M., Bailey, Dale L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843622/
https://www.ncbi.nlm.nih.gov/pubmed/33510222
http://dx.doi.org/10.1038/s41598-021-81910-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843622/
https://www.ncbi.nlm.nih.gov/pubmed/33510222
http://dx.doi.org/10.1038/s41598-021-81910-4

Ejemplares similares